ArticleCell cycle (Georgetown, Tex.)2019

miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.

Qing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.